AIM ImmunoTech Inc.

Form 4 AIM ImmunoTech Inc: Thomas K. Equels (Director, CEO & President) For: 22 October
Investing.com India · 23 Oct 2026
Aim ImmunoTech CEO Equels buys $5,093 of common stock By Investing.com
Investing.com Canada · 23 Oct 2026
AIM ImmunoTech Inc. Stock Price Prediction: Today, Tomorrow, Next Week (AIM)
Traders Union · 13 Oct 2026
AIM ImmunoTech Spotlights Growing Attention Around
GlobeNewswire · 01 Oct 2026
AIM ImmunoTech Discusses Ampligen®’s Potential to
GlobeNewswire · 30 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.